Researchers is significantly improved its progress of the innovative therapy for ATTR-CM, utilizing Attruby. Early clinical information reveals potential improvements for individuals diagnosed by the severe disease. The effort highlights the company’s focus to treating critical medical needs in this heart disease space. Attruby: BridgeBio's Nove